LNTH(Lantheus Holdings, Inc.) 的财务报表:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $425.21M | $935.06M | $1.30B | $1.53B | $1.54B |
| 毛利润 | $187.69M | $581.70M | $709.54M | $988.29M | $941.95M |
| 营业利润 | −$60.83M | $36.20M | $364.64M | $456.98M | $310.83M |
| 净利润 | −$71.28M | $28.07M | $326.66M | $312.44M | $233.56M |
| 经营现金流 | $53.92M | $281.78M | $305.26M | $544.75M | $390.14M |
| 自由现金流 | $53.92M | $21.78M | $259.92M | $493.12M | $354.05M |
| 摊薄每股收益 | $-1.06 | $0.40 | $4.65 | $4.36 | $3.41 |